Blocking PAK1 enhances ovarian cancer response to PARP inhibitors
A new molecular strategy could crack open a stubborn bottleneck in ovarian cancer therapy, offering hope to patients whose tumors ...
A new molecular strategy could crack open a stubborn bottleneck in ovarian cancer therapy, offering hope to patients whose tumors ...
In a groundbreaking study published recently in Nature Communications, a team of researchers led by Boonen, Knaup, and Menafra have ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine